Clinical Trial Update: Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients [Phase 2]

View source ↗

Summary

Clinical trial update indicates Tegoprubart is being studied in Phase 2 for long-term safety and efficacy in kidney transplant recipients, with enrollment by in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Rejection

Drugs mentioned

• Tegoprubart

Snippet

Sponsor: Eledon Pharmaceuticals | Conditions: Kidney Transplant Rejection | Phase 2 | Status: ENROLLING_BY_INVITATION